FDA approves AtriCure's Synergy cardiac ablation device

December 16, 2011 by MassDevice staff

AtriCure gets a modest bump on Wall Street after the FDA OK's its Synergy radiofrequency device, the first cardiac ablation device approved for treating atrial fibrillation in the U.S.

Comments